Clinical Trials Logo

CHF clinical trials

View clinical trials related to CHF.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05843201 Completed - Clinical trials for Chronic Heart Failure

AquaPass Device in Treatment of CHF Patients

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

The AquaPass System is intended for enhancing fluid transfer through the skin, by increased sweat rate, in fluid overloaded patients. This study will examine safety, performance and usability of the AquaPass device in two phases: Phase 1: Hospitalization treatment. Phase 2: Home/outpatient clinic treatment

NCT ID: NCT04261452 Completed - COPD Clinical Trials

Heart Failure Worsens Muscle Strength in COPD

Start date: August 1, 2014
Phase: N/A
Study type: Interventional

The combination of heart failure (HF) and chronic obstructive pulmonary disease (COPD) is highly prevalent, but underdiagnosed and poorly recognized. It has been suggested that the decline in functional capacity is associated with musculoskeletal and systemic changes than primary organ (heart and/or lung) failure. In addition, it is recognized that both diseases have several mechanisms that are responsible for musculoskeletal impairment. However, the association of reduced systemic perfusion with low oxygen content observed in the association of HF and COPD may contribute to the worsening of the components of the muscle impairment cascade. Thus, muscle strength and fatigue may not only be even more altered but may also be the main determinants of functional capacity in patients with coexistence of HF and COPD. Although many studies have evaluated the muscle performance of patients with HF or COPD, the literature did not show data on worsening due to the association of the diseases. Particularities identification of the muscle impairment in the coexistence of HF and COPD is fundamental for the development of rehabilitation strategies, mainly through physical exercise. In this line, the present study tested the hypothesis that the coexistence of HF and COPD could present lower values of strength and greater fatigue. Similarly, the muscle dysfunction degree could strongly correlate with the performance markers of the incremental or functional tests in patients with HF associated with COPD. The study protocol was reviewed and approved by the Institutional Research Board. All subjects gave written informed consent before participating in the study.

NCT ID: NCT03808948 Completed - CHF Clinical Trials

FAST PV and mGFR™ Technology in Congestive Heart Failure

Start date: January 10, 2019
Phase: N/A
Study type: Interventional

This is an investigator-initiated, one-armed, phase 2 clinical trial using an injectable fluorescent tracer to assay and evaluate measured plasma volume (mPV) and measured glomerular filtration rate (mGFR) in hospitalized patients with acute decompensated congestive heart failure (CHF).

NCT ID: NCT03463148 Completed - Hypertension Clinical Trials

Validation of a Sensor for Non-Invasive Measurements

Start date: October 24, 2017
Phase:
Study type: Observational

Subjects will be measured with both a sensor and a reference device

NCT ID: NCT03339310 Completed - Heart Failure Clinical Trials

Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System

FIX-HF-5C2
Start date: October 23, 2017
Phase: N/A
Study type: Interventional

This is a multicenter, prospective, single-arm study of the Optimizer Smart System with 2-leads

NCT ID: NCT03207802 Completed - CHF Clinical Trials

Remotely Monitoring Patients With Chronic Conditions in Their Home

Start date: June 21, 2017
Phase:
Study type: Observational

Study will collect data from the home using the CoVa Monitoring System. Data will be captured and retrospectively analysis to determine if the data provided can alert clinician about a patient's declining health.

NCT ID: NCT02632552 Completed - COPD Clinical Trials

A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD

TACT
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Transition from hospital to home places patients in jeopardy of adverse events and increases their risk for rehospitalization. CHF is the most prevalent chronic condition among U.S. adults and COPD is the third leading cause of death in the U.S. Both CHF and COPD represent significant burdens for the VHA healthcare system. Care transitions can be supported through multi-component interventions, but are costly to implement. Virtual nurses provide an effective medium for explaining health concepts to patients, and previous work indicates patients find virtual nurses acceptable. The investigators will implement and evaluate a virtual nurse intervention to provide automated, tailored, and timely support to Veterans transitioning from hospital to home. As effective care transition interventions incorporate both inpatient and outpatient components, the virtual nurse will first engage with patient onscreen during their inpatient stay and then via text message post-discharge. This project has the potential to improve the care transition experience for patients, caregivers and healthcare providers.

NCT ID: NCT01316432 Completed - Heart Failure Clinical Trials

PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients

Start date: May 2011
Phase: Phase 1
Study type: Interventional

The purposed of the study is to evaluate the pharmacokinetics (PK) response of continuous subcutaneous (SQ) infusion of cenderitide, as compared with a single SQ bolus.

NCT ID: NCT00288587 Completed - Heart Failure Clinical Trials

Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)

Start date: October 2003
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess the ability of Ultrafiltration to influence the rate of hemodynamic improvement, as measured by the decline in the pulmonary artery occlusion pressure, in patients with NYHA class III/IV Heart Failure.